Dactolisib

DRUG2 trials

Sponsors

Restorbio Inc.

Conditions

Clinically Symptomatic Respiratory IllnessRespiratory Tract Infections

Phase 3

Effect of RTB101 on Illness Associated With Respiratory Tract Infections in the Elderly

WithdrawnNCT04139915

Restorbio Inc.Clinically Symptomatic Respiratory Illness

Start: 2019-10-21End: 2019-11-15Updated: 2019-11-22

A Phase 3 Study to Determine if RTB101 Prevents Clinically Symptomatic Respiratory Illness in the Elderly

CompletedNCT04668352

Restorbio Inc.Respiratory Tract Infections

Start: 2019-04-15End: 2019-12-02Updated: 2021-06-23